Taro Pharma Industries Gets FDA Approval For Its "ANDA" Of Ciclopirox Topical Solution - Quick Facts (Nasdaq)
(RTTNews) - Taro Pharmaceutical Industries Ltd. (TAROF.PK) announced that it has received approvals from the U.S. Food and Drug Administration for its Abbreviated New Drug Application or "ANDA" for Ciclopirox Topical Solution, 8% (Nail Lacquer) ("ciclopirox nail lacquer") and its Supplemental ANDA for Loratadine Syrup (Oral Suspension), 5 mg/5 mL ("loratadine syrup") in a grape flavored ...

TAROF: FDA Approves Generic Penlac(R) Nail Lacquer and Claritin(R) Syrup (Nasdaq)
Taro Pharmaceutical Industries Ltd. (TAROF) received approvals from the FDA for its Abbreviated New Drug Application ("ANDA") for Ciclopirox Topical Solution, 8% (Nail Lacquer), and its Supplemental ANDA for Loratadine Syrup (Oral Suspension), a 5 mg/5 mL in a grape flavored formulation and over-the-counter product.

St. Jude Medical Announces FDA Approval Of Company's First Radiofrequency Wireless ICD And CRT-D Heart Failure Devices (Medical News Today)
St. Jude Medical, Inc. (NYSE:STJ) announced U.S. Food and Drug Administration (FDA) approval of its first radiofrequency (RF) wireless devices to treat patients with heart failure and with potentially lethal heart arrhythmias. [click link for full article]